Prognostic Evaluation of Vitrectomy Assisted by Lucentis in Diabetic Retinopathy and Neovascular Glaucoma

Xuli Zhao, Yakun Wang

Open source

DOI
10.1155/2022/4127293
Published
2022-08-01
Container
Evidence-Based Complementary and Alternative Medicine
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/4127293,
  title = {Prognostic Evaluation of Vitrectomy Assisted by Lucentis in Diabetic Retinopathy and Neovascular Glaucoma},
  author = {Xuli Zhao and Yakun Wang},
  year = {2022},
  journal = {Evidence-Based Complementary and Alternative Medicine},
  doi = {10.1155/2022/4127293},
  url = {https://doi.org/10.1155/2022/4127293}
}

RIS

TY  - JOUR
TI  - Prognostic Evaluation of Vitrectomy Assisted by Lucentis in Diabetic Retinopathy and Neovascular Glaucoma
AU  - Xuli Zhao
AU  - Yakun Wang
PY  - 2022
JO  - Evidence-Based Complementary and Alternative Medicine
DO  - 10.1155/2022/4127293
UR  - https://doi.org/10.1155/2022/4127293
ER  - 

APA

Zhao, X., & Wang, Y. (2022). Prognostic Evaluation of Vitrectomy Assisted by Lucentis in Diabetic Retinopathy and Neovascular Glaucoma. Evidence-Based Complementary and Alternative Medicine. https://doi.org/10.1155/2022/4127293

Source records